AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Colt CZ Group SE

Investor Presentation Sep 18, 2025

1046_rns_2025-09-18_4b152e45-f623-4d09-9f8f-8c1ac47ec323.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

COLT CZ GROUP SE FINANCIAL RESULTS 6M 2025

INVESTOR PRESENTATION

LEGAL DISCLAIMER

IMPORTANT – YOU MUST READ THE FOLLOWING BEFORE CONTINUING

  • This presentation (the "Presentation") has been prepared by Colt CZ Group SE, with its registered office at náměstí Republiky 2090/3a, Nové Město, 110 00 Praha 1, Identification Number 291 51 961, registered in the Commercial Register maintained by the Municipal Court in Prague, Section H, Insert 962 (the "Colt CZ"). By attending the meeting where this Presentation is made or by reading the Presentation document, you agree to be bound by the following terms and conditions.
  • The Presentation has been prepared with due care. However, certain inconsistencies or omissions might have appeared herein. Therefore, it is recommended that any person intending to undertake any investment decision on any security issued by Colt CZ or any member of its group (the "Group") shall only rely on information released as an official communication by Colt CZ in accordance with the legal and regulatory provisions that are binding for Colt CZ.
  • Past performance can not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. Colt CZ does not (i) warrant that the assumptions underlying the forward-looking statements in this Presentation are free from errors, (ii) accept any responsibility for the future accuracy of the opinions expressed in this Presentation, or (iii) undertake any obligation to update the statements in this Presentation to reflect subsequent events. The forward-looking statements in this Presentation are made only as of the date hereof. Neither delivery of this Presentation nor any further discussions between Colt CZ and you shall, under any circumstances, result in any implication that there has been no change in Colt CZ affairs since such date.
  • Forward-looking statements, including statements relating to expectations regarding future financial results, give no guarantee or assurance that such results will be achieved. Expectations of the Colt CZ management are based on present knowledge, awareness and/or views of the management members and are dependent on many factors, which may cause the actual results that Colt CZ will achieve may differ materially from those discussed in this Presentation. Many such factors are beyond the present knowledge, awareness and/or control of Colt CZ, or cannot be predicted. None of the Group, Colt CZ or its directors, managers, advisers or representatives of such persons makes any representation or warranty, expressed or implied, as to (i) the fairness, accuracy, completeness or correctness of this Presentation, (ii) the sufficiency of this Presentation for your purposes. or (iii) the appropriateness of this Presentation for any purpose other than that for which it was intended. Nothing contained herein is or should be relied upon as a promise or representation, whether as to the past or the future.
  • This Presentation should not be construed as legal, regulatory, tax, accounting, investment or other advice. Nothing contained herein shall constitute any representation or warranty as to the future performance of any security, credit, currency, rate or other market or economic measure. No reliance may be placed for any purpose whatsoever on this Presentation.
  • This Presentation was prepared for information purposes only and is neither a purchase nor sale offer nor a solicitation of a n offer to purchase or sell any securities or financial instruments or an invitation to participate in any commercial venture. This Presentation is neither an offer nor an invitation to purchase or subscribe for any securities in any jurisdiction, and no statements contained herein may serve as a basis for any agreement, commitment or investment decision, or may be relied upon in connection with any agreement, commitment or investment decision.

AGENDA AND TODAY'S PRESENTERS

AGENDA PRESENTERS

JAN DRAHOTA Chairman of the Board of Directors Colt CZ Group SE

RADEK MUSIL Vice-chairman of the Board of Directors CEO of Colt CZ Group SE

JAN ZAJÍC Member of the Board of Directors CEO of Česká zbrojovka a.s.

JANA MATOUŠKOVÁ Head of Group Finance Colt CZ Group SE

6M 2025 AT A GLANCE

REVENUES CZK 11,015 m ↑ 13.7% vs 6M 2024 LTM: CZK 24,579 m ADJUSTED EBITDA CZK 2,361 m ↑ 19.2% vs 6M 2024 LTM: CZK 5,210 m

ADJUSTED NET PROFIT CZK 1,002 m ↓ 1.3% vs 6M 2024 LTM: CZK 2,067 m

PPA IMPACT CZK 303 m or CZK 5.3 per share

ADJUSTED EPS ↓ 28.4% vs 6M 2024 CZK 17.8 LTM: CZK 37.4

COMMENTS ON 6M 2025 PERFORMANCE

Ammunition segment retains excellent profitability, growing on the European market, able to offset US commercial market softness.

Firearms - H1 2025 performance slower than expected for CZ and Colt WH, only Colt Canada performed above 2024 YTD.

CZ is doing well on the slower US commercial market (flat y/y even with price increase), but some key MLE project delayed to Q3 and Q4, expected to catch up in Q3 and Q4.

Colt WH - weakest performer of the Group in 2025 - both on the US commercial market (slower introduction of new models), delay in key large MLE contracts (some of them record high, but regulatory process taking longer than expected).

US tariffs in majority passed on the consumer (firearms), to the sales price, FX rates influencing the Revenues/EBITDA (apart of the translation risk offset in the financial income of the Group).

Sellier & Bellot, has signed a five-year strategic partnership agreement for the supply of high-performance propellants with EURENCO. Česká zbrojovka signed Framework Agreement with Ministry of Defence for the years 2025 to 2031. Colt Canada signed a significant contract with the Danish Ministry of Defence Acquisition and Logistics (DALO), for the supply of 26,000 C8 MRR carabines.

REVENUES – EUROPE PLAYS A KEY ROLE

In % of total revenues In % of total revenues

REVENUE BREAKDOWN BY GEOGRAPHY REVENUE BREAKDOWN BY GEOGRAPHY – SEGMENTS

REVENUES AND EBITDA MARGIN – OWN PRODUCTION VS TRADING

CUSTOMER SEGMENTS

HIGHER SEASONALITY AND US COMMERCIAL MARKET SLOWDOWN

186 175 137 115 323 290 6M 2024 6M 2025 -10% In '000 units

BREAKDOWN BY FIREARMS UNITS SOLD

CZ BRAND

COLT BRAND

In '000 units

Short guns Long guns

ADJUSTED NET PROFIT WITHOUT S&B PPA AMORTIZATION EFFECT

NET PROFIT EARNINGS PER SHARE

CAPEX IN LINE WITH 2025 GUIDANCE

CAPITAL EXPENDITURES 1 CAPEX GEOGRAPHICAL SPLIT

COMMENTS

FY 2025 CAPEX guidance in line with medium-term strategy

Main part of CAPEX 2025 was realized in the Czech Republic in both – R&D and machinery

INDEBTEDNESS

EXPECTED DEBT MATURITY PROFILE

(INC. ACQUISITION FINANCING) NET FINANCIAL DEBT 1 & NET LEVERAGE RATIO 2

COMMENTS

  • In June group repaid part of the S&B acquisition loan of EUR 43 m
  • In June VSS acquisition price of USD 62m paid
  • Cash generative business of both businesses will allow leverage reduction going forward, with expected acquisition
  • SNC acquisition pro-forma impact on slide 16

Notes: 1 – Net financial debt is defined as long-term and short-term bonds, bank loans and borrowings and finance lease liabilities (non-current and current), less cash and cash equivalents, less other current financial assets (marketable securities) 2 – Net leverage ratio is defined as the ratio of net financial debt at the end of the period to LTM adjusted EBITDA, formula based on the loan legal documentation

SYNTHESIA ACQUISITION TRULY TRANSFORMATIVE FOR THE GROUP

The transaction values 100% of SNC at CZK 20.6bn and 100% of energy business, at CZK 1.4bn at Enterprise Value

Transaction multiple at 8.2x EV/EBITDA

Current Colt CZ trading multiple 9-10x

Producers of military propellants and explosives (Chemring, Rheinmetall, BAE) trade at ~ 15x-35x EV/EBITDA

The extension of our core business into a new segment should allow for multiple expansion

Colt CZ signed SPA for acquisition of 51% of SNC for CZK 10.5bn Enterprise Value

Cash consideration of CZK 5.5bn

Expected stock consideration of around CZK 3.7bn based on the following assumptions at closing:

  • Net Debt EUR 107m
  • No working capital adjustment
  • 180 trading days VWAP (as of 15/9/2025 CZK 710) to be used also for PUT options
  • ~ 5m new shares, Kaprain to become 3rd largest shareholder at around 8% of capital

51% of Energy business will be acquired in 1HY 2026

Expected stock consideration CZK 714m based on the following assumptions at closing:

  • Net Debt = 0
  • No working capital adjustment
  • 180 trading days VWAP (as of 15/9/2025 CZK 710)
  • ~ 1m new shares, stake of Kaprain increases to around 9%

PUT/CALL MECHANISM FOR THE REMAINING 49% STAKE

PUT option of KAPRAIN for remaining 49% of SNC for CZK 10.1bn Enterprise Value

Exercise period during 2 years starting 24 months after closing Cash consideration CZK 3.5bn Expected stock consideration CZK 5.3bn based on the following assumptions at the second closing:

  • Net Debt EUR 107m
  • ~ 6m new shares

CALL option of COLT CZ GROUP for remaining 49% of SNC for CZK 10.1bn Enterprise Value

Exercise period during 2 years starting 48 months after closing All cash consideration CZK 8.8bn based on the following assumptions at the second closing:

Net Debt EUR 107m

PUT/CALL option for remaining 49% of Energy

Exercise period same as SNC Expected stock consideration at CZK 686m adjusted for actual net debt

NCS PRO-FORMA IMPACT 2025

EXPECTED TIMING

  • Signing 8/2025
  • NCS Closing 11/2025 Q1 2026
  • Carve-out of energy business into a separate company
  • Acquisition of 51% in energy business by H1 2026
  • Acquisition of remaining 49% in SNC and energy business, 2028-2032

16

PRIORITIES AND GUIDANCE 2025

REVENUES

CZK 25 bn plus/minus 10% EBITDA CZK 5.5 bn plus/minus 10%

Net interest costs CZK 599 mio

Indicative split per quarters (updated)

CZK bn Q
1
Q
2
Q
3
Q
4
FY 2025
Revenues 5.5 5.5 5.0 9.0 25
Adj. EBITDA 1.2 1.1 1.2 2.0 5.5

Notes: Guidance is based on the management expectations as of the date of presentation SNC acquisition not included

RISKS AND OPPORTUNITIES FOR GUIDANCE

RISKS

  • Further deterioration of the US commercial market, global economic outlook
  • Timing to market of key products in the pipeline
  • Several significant M&LE projects still to be finalized to be able to start potential deliveries (strongly weighed towards Q3 and Q4 of 2025)
  • FX volatility of EUR and USD versus CZK
  • Potential impact of US tariffs

OPPORTUNITIES

  • Some of the potential contracts will be historically large for the Group if finally signed, and deliveries start in 2025.
  • Impact of trading activities of non-produced products should be more significant in terms of profitability in 2025, but still uncertainty on timing/size.
  • Timely finalization of SNC closing still in 2025

THANK YOU FOR YOUR ATTENTION

APPENDIX

ADJUSTED EBITDA RECONCILIATION

In CZK '000 6M 2025 6M 2024
Operating profit 1 587 284 898 774
Depreciation and amortization 770 968 560 821
EBITDA 2 358 252 1 459 595
ESOP related costs 30 945 382 185
M&A costs 15 218 962
Legacy costs 5 389 -
S&B inventory step up - 110 000
S&B commodity hedging (48 734) 28 016
Adjusted EBITDA 2 361 069 1 980 758

ADJUSTED NET PROFIT RECONCILIATION

In CZK '000 6M 2025 6M 2024
Earnings before tax 1 195 680 794 788
Tax expenses (276 414) (185 170)
Net income 919 266 609 618
ESOP related costs 30 945 382 185
M&A costs 15 218 962
Legacy cost 5 389 -
S&B inventory step up - 110 000
Bank fee – acquisition loan S&B 41 761 30 634
Expenses of IRS cancellation related to early repayment of loan 7 955 -
One-off expenses related to the bond issue 6 402 4 838
Adjusted earnings before tax (Adj. EBT) 1 303 350 1 323 407
Effective tax rate on Adj. EBT (2025 ~23.1%; 2024 ~23.3%) (301 305) (308 328)
Adjusted Net Income 1 002 045 1 015 079

NET INTEREST COSTS GUIDANCE

In CZK '000 000; G 2025
Interest expenses 852
Hedging impact (112)
Deposit revenues (141)
Net interest costs 599
Effective interest rate 3,64%

ASSUMPTIONS

Stable FX rate EUR/CZK

  • No extraordinary debt repayment
  • Stable market interest rates
  • No additional debt financing included

CONSOLIDATED PROFIT AND LOSS STATEMENT

In '000 CZK 30 Jun 2025 30 Jun 2024
Revenues from the sale of own products, goods and services 11 014 802 9 690 015
Other operating income 850 778 217 161
Change in inventories developed internally (5 570 674) (5 453 456)
Own work capitalized (2 502 828) (2 226 294)
Raw materials and consumables used (770 968) (560 821)
Services (1 331 255) (1 098 262)
Personnel costs 55 243 67 122
Depreciation and amortization 143 985 406 861
Other operating expenses (259 231) (164 827)
Allowances (42 568) 21 275
Operating profit 1 587 284 898 774
Interest income 281 015 418 014
Interest expense (556 672) (558 422)
Other financial income 3 233 85 496
Other financial expenses (373 343) (63 837)
Gains or losses from derivative transactions 250 323 13 854
Share in the profit of associates after tax 3 840 909
Profit before tax 1 195 680 794 788
Income tax (276 414) (185 170)
Profit for the period 919 266 609 618
Items that may be subsequently reclassified to the statement of profit or loss
Cash flow hedges – remeasurement of effective portion of hedging instruments 382 339 (179 440)
Foreign currency translation of foreign operations (306 975) 25 528
Other comprehensive income 75 364 (153 912)
Comprehensive income for the period 994 630 455 706
Profit for the period attributable to:
Owner of the parent company 919 266 609 618
Comprehensive income for the period attributable to:
Owner of the parent company 994 630 455 706
Net earnings per share attributable to the owner of the parent company (CZK per share)
Basic 16 15
Diluted 16 15

CONSOLIDATED BALANCE SHEET 1/2

In CZK '000 30 Jun 2025 31 Dec 2024
ASSETS
Non-current assets
Intangible assets 9 797 868 10 403 416
Goodwill 9 025 018 8 489 707
Property, plant and equipment 9 779 922 9 582 545
Equity-accounted securities and investments 47 943 44 102
Financial derivatives 844 755 413 372
Trade and other receivables 11 766 20 021
Other receivables 2 132 2 593
Deferred tax assets 72 269 75 589
Total non-current assets 29 581 673 29 031 345
Current assets
Inventories 8 809 146 7 456 512
Trade and other receivables 2 066 369 2 829 759
Provided loans 19 180 20 017
Other financial assets 11 134 12 531
Financial derivatives 465 245 127 174
Other receivables 440 095 555 882
Tax receivables 154 385 81 210
Cash and cash equivalents 3 452 305 5 917 768
Total current assets 15 417 859 17 000 853
Total assets 44 999 532 46 032 198

CONSOLIDATED BALANCE SHEET 2/2

In CZK '000 30 Jun 2025 31 Dec 2024
EQUITY AND LIABILITIES
Capital and reserves
Share capital 5 646 5 646
Share premium 13 477 795 13 477 795
Capital funds 1 641 512 1 641 512
Cash flow hedge reserve 178 845 (203 494)
Foreign exchange translation reserve (375 112) (68 137)
Accumulated profits 5 276 568 5 175 107
Equity attributable to the owner of the Company 20 205 254 20 028 429
Non-controlling interest - -
Total equity 20 205 254 20 028 429
Non-current liabilities
Bonds, bank loans and borrowings 14 494 844 16 336 227
Financial derivatives 217 510 532 473
Lease liabilities 53 390 58 922
Trade and other payables 68 726 46 802
Other payables 7 289 10 387
Provisions 101 732 101 095
Deferred tax liability 2 602 536 2 561 948
Employee benefit liabilities 204 085 234 725
Total non-current liabilities 17 750 112 19 882 579
Current liabilities
Bonds, bank loans and borrowings 1 499 060 1 474 910
Financial derivatives 259 778 394 262
Lease liabilities 21 457 22 267
Trade and other payables 2 394 545 1 573 335
Other payables 2 654 952 2 333 203
Provisions 79 191 57 870
Tax liabilities 117 329 248 236
Employee benefit liabilities 17 854 17 107
Total current liabilities 7 044 166 6 121 190
Total liabilities 24 794 278 26 003 769
Total equity and liabilities 44 999 532 46 032 198

CONSOLIDATED CASH FLOW STATEMENT

In '000 CZK 30 Jun 2025 30 Jun 2024
Cash flows from principal economic activity (operating activity)
Profit from ordinary activity before tax 1 195 680 794 788
Depreciation/amortization of non-current assets 770 968 560 821
Change in allowances and provisions 69 504 24 940
Gain/Loss on sale of fixed assets (1 159) (1 392)
Interest expense and interest income 275 657 140 408
Share in the profit of associates (3 841) (909)
Unrealized foreign exchange gain and losses 830 216 (133 551)
Other financial assets – remeasurement - (113 402)
Cash flow hedging – remeasurement of the effective portion of hedging instruments 382 339 (179 440)
Share-based payments 29 140 355 013
Adjustments for other non-cash transactions 57 277 31 380
Net operation cash flows before changes in working capital 3 605 781 1 478 656
Change in working capital (1 609 371) (430 769)
Change in receivables and deferrals (44 842) (189 676)
Change in liabilities and accruals 149 946 (161 031)
Change in inventories (1 714 475) (80 062)
Cash flow from operating activities 1 996 410 1 047 887
Paid interest (704 810) (525 585)
Interest received 429 443 429 610
Income tax paid for ordinary activity (587 099) (521 795)
Net cash flow from operating activities 1 133 944 430 117
Cash flows from investing activities
Acquisition of non-current assets (361 963) (382 502)
Proceeds from the sale of non-current assets 1 159 1 392
Acquisition of equity-accounted securities and investments - (3 777)
Acquisition of subsidiaries - opening balance (1 341 795) (5 231 350)
Acwuidizion of subsidiaries - cash and cash equivalents 8 460 443 521
Employee benefit liabilities - -
Acquisition of other financial assets - -
Proceeds from sale of other financial assets - 1 021 982
Provided loans - (18 979)
Net cash flow from investing activities (1 694 139) (4 169 713)
Cash flows from financing activities
Proceeds from issue of bonds - 276 000
Proceeds from loans 2 378 10 794 456
Loan repayment (1 726 254) (5 701 743)
Leases repayment (13 840) (12 966)
Net cash flow from financing activities (1 737 716) 5 355 747
Net change in cash and cash equivalents (2 297 911) 1 616 151
Opening balance of cash and cash equivalents 5 917 768 3 328 684
Effect of exchange rate on cash and cash equivalents (167 552) 53 002
Closing balance of cash and cash equivalents 3 452 305 4 997 837

ACQUISITION OF SELLIER & BELLOT – D&A IMPACT

COMMENTS

  • Increase in Amortization due to Purchase Price Allocation of S&B acquisition significantly affecting Net profit/EPS
  • Significant impact on net profit and EPS in the next 3 years, approximately CZK 600 m impact on the net profit per year

COLT CZ GROUP STRUCTURE

29

THANK YOU

Colt CZ Group SE

náměstí Republiky 2090/3a 110 00 Prague 1, Czech Republic www.coltczgroup.com [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.